Showing results (11-20 of 210) with videos related to
Sort By:
Pageof 21
Basic Research in Cardiology|January 1, 1994
Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabainD Baumgart, T Ehring, M Krajcar, et al.Basic Research in Cardiology|May 1, 1992
Three-dimensional analysis of regional mechanical function, blood flow and electrophysiological parameters during early myocardial ischemia in dogsP Kowallik, D Baumgart, A Skyschally, et al.Journal of Molecular and Cellular Cardiology|March 1, 1996
Aspirin does not prevent the attenuation of myocardial stunning by the ACE inhibitor ramiprilatJ Rose, T Ehring, S G Sakka, et al.The American Journal of Physiology|February 1, 1995
Cholinergic and alpha-adrenergic coronary vasomotion [corrected] with increasing ischemia-reperfusion injuryT Ehring, M Krajcar, D Baumgart, et al.Circulation|September 1, 1994
Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxideT Ehring, D Baumgart, M Krajcar, et al.Circulation Research|November 1, 1993
Impact of alpha-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activationD Baumgart, T Ehring, P Kowallik, et al.Basic Research in Cardiology|July 6, 2000
X-ray densitometry for the measurement of regional myocardial perfusionM Haude, G Caspari, D Baumgart, et al.Schweizerische Medizinische Wochenschrift|September 28, 1996
[Pathophysiology of ischemic myocardial dysfunction]G HeuschZeitschrift Fur Kardiologie|November 1, 1992
[Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?]G HeuschBritish Journal of Pharmacology|January 29, 2008
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agentsG HeuschPageof 21